Ofev
NICE changes stance on Sanofi’s Dupixent for severe asthma
Phil Taylor
Boehringer Ingelheim, HEOR, NHS, NICE, Ofev, rare disease, Regeneron, respiratory, Sanofi, severe asthma
0 Comment
X
NICE changes stance on Sanofi’s Dupixent for severe asthma
https://pharmaphorum.com/news/nice-changes-stance-on-sanofis-dupixent-for-severe-asthma/